Important pharmacy news and late-breaking industry information updated daily.
The Trump administration last week released a proposal that, if finalized, would allow states, wholesalers, and pharmacies to creep toward importing drugs from foreign nations. A second proposed policy would allow manufacturers to import their own products sold abroad. The policies must survive multiple regulatory hurdles—which could take months or years—before they can be implemented.
Despite the prominence of the issues for both Republicans and Democrats, only one drug pricing policy will cross the finish line in 2019.
CDC is warning doctors to more closely monitor patients with severe lung damage caused by vaping, because some have relapsed or died shortly after being sent home from the hospital.
FDA on Thursday announced the approval of Ervebo, the first agency-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals aged 18 years and older. The Democratic Republic of the Congo (DRC) is currently experiencing the world’s second largest EVD outbreak.
The Trump administration on Wednesday unveiled a plan to allow states, drug wholesalers, and pharmacies to import some cheaper drugs from Canada. However, officials could not say when the plan might go into effect, and many questions about its possible scope remain unanswered.
A growing number of U.S. teenagers are vaping THC, new research in the Journal of the American Medical Association shows.
The popular diabetes medication—metformin—is the latest to come under scrutiny from FDA for being tainted with the suspected human carcinogen N-nitrosodimethylamine (NDMA). The agency is testing samples of metformin sold in the United States but has not announced any recalls to date and said patients should continue to take their treatment as prescribed.
Members of the Sackler family, withdrew more than $10 billion from Purdue Pharma as scrutiny of the company's role in the opioid epidemic intensified over the past 12 years. The family members distributed the money among trusts and overseas holding companies, according to a new audit commissioned by Purdue.
FDA on Friday approved the use of icosapent ethyl (Vascepa—Amarin) as an adjunctive therapy to lower the risk of cardiovascular (CV) events among adults with elevated triglyceride levels of 150 mg/dL or higher. Additionally, patients must have either established CV disease or diabetes and two or more other risk factors for CV disease.
Senate Finance Committee leaders Sens. Chuck Grassley (R-IA) and Ron Wyden (D-OR) have released a new drug pricing bill that includes language that would require price concessions to be included in the negotiated price at point of sale (POS) under Medicare Part D. The change would take effect on January 1, 2022. The bipartisan S. 2543, the Prescription Drug Pricing Reduction Act, would also prohibit plans from retroactively recouping fees while allowing post-POS bonuses and moves up the timeline for standard quality metrics to 2022. Read the new language addressing direct and indirect remuneration (DIR fees) and other pharmacy issues here.